-
3600 AED
myCardioΒ is a service for the diagnosis of hereditary cardiovascular disease based on exome sequencing and the study of 100 genes selected by a team of experts in cardiovascular genetics.
-
4000 AED
Customized Exome PanelsΒ are specialized genetic tests that focus on sequencing selected genes or regions of the exome based on a patientβs specific clinical needs.
- Customized Exome panel from 1 to 20 interpreted genes
- Customized Exome panel from 20 to 75 interpreted genes
- Customized Exome panel from 75 to 200 interpreted genes
- Customized Exome panel over 200 interpreted genes
-
3000 AED
MyFull GenomeΒ is the complete genome sequencing and interpretation service to prevent disease and improve the health of your patients. The test is aimed at any healthy patient who is proactive in taking care of their health. The test evaluates over +650 clinical conditions that may have clinical significance on the patient such as diseases, cardiovascular, oncology, multifactorial diseases, pharmacogenomics, diseases transmissible to offspring and personal genetic traits.
-
3600 AED
myGeneticRiskΒ is the preventive genetic test that allows to know the hereditary risk of cardiovascular diseases and cancer, the most frequent pathologies worldwide. Knowing the predisposition to these diseases allows the specialist to establish medical management strategies to prevent them or detect them in the early stages, where it is possible to treat them effectively.
Study of 162 genes related to diseases with clinical relevance on which it is possible to act to prevent or detect them early. The test analyzes genes related to cardiovascular conditions and cancer risk and completes the analysis with other diseases whose study is recommended by the ACMG (American College of Medical Genetics and Genomics).
-
6200 AED
MyOnco RiskΒ is a genetic test that determines the risk of hereditary cancer through complete exome sequencing and the subsequent study of 40 genes related to the most common hereditary cancers such as breast and ovarian cancer.
End of content
End of content